The Patent Finder

Molecular Templates, Inc.

16 patents currently held · Updated Nov 15, 2026
11 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Threshold Pharmaceuticals, Inc. (to 2018)

1
Ending by 2030
Jun 2030
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 27, 2027
    The maintenance fee for Multivalent CD20-Binding Molecules Comprising Shiga Toxin a Subunit Effector Regions and Enriched Compositions Thereof (US 10,392,425) comes due Feb 27, 2027. Unpaid by Aug 27, 2027, it lapses early.
  • 1 fee due Mar 24, 2027
    The maintenance fee for Methods of Screening, Selecting, and Identifying Cytotoxic Recombinant Polypeptides Based on an Interim Diminution of Ribotoxicity (US 10,421,958) comes due Mar 24, 2027. Unpaid by Sep 24, 2027, it lapses early.
  • 1 fee due Apr 22, 2027
    The maintenance fee for CD20-Binding Immunotoxins for Inducing Cellular Internalization and Methods Using Same (US 10,450,354) comes due Apr 22, 2027. Unpaid by Oct 22, 2027, it lapses early.
  • 1 fee due Jul 2, 2027
    The maintenance fee for Shiga Toxin a Subunit Effector Polypeptides, Shiga Toxin Effector Scaffolds, and Cell-Targeting Molecules for Site-Specific Conjugation (US 11,857,628) comes due Jul 2, 2027. Unpaid by Jan 3, 2028, it lapses early.
  • 1 fee due Sep 5, 2027
    The maintenance fee for PD-L1-BINDING Molecules Comprising Shiga Toxin a Subunit Scaffolds (US 11,918,649) comes due Sep 5, 2027. Unpaid by Mar 6, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,765,690Treatment of Cancer with Glufosfamide in Patients Not Receiving Insulin Therapy
In force
 · High confidence
In forceHigh confidence
US 10,815,469Cell-Targeting Molecules Comprising Protease-Cleavage Resistant, Shiga Toxin A Subunit Effector Polypeptides and Carboxy-Terminal Moieties
In force
 · High confidence
In forceHigh confidence
US 12,065,469De-Immunized Shiga Toxin a Subunit Effector Polypeptides for Applications in Mammals
In force
 · High confidence
In forceHigh confidence
US 12,637,495De-Immunized Shiga Toxin a Subunit Effector Polypeptides for Applications in Mammals
In force
 · Medium confidence
In forceMedium confidence
US 10,421,958Methods of Screening, Selecting, and Identifying Cytotoxic Recombinant Polypeptides Based on an Interim Diminution of Ribotoxicity
In force
 · High confidence
In forceHigh confidence
US 10,450,354CD20-Binding Immunotoxins for Inducing Cellular Internalization and Methods Using Same
In force
 · High confidence
In forceHigh confidence
US 12,037,367MHC Class I Epitope Delivering Polypeptides
In force
 · High confidence
In forceHigh confidence
US 10,392,425Multivalent CD20-Binding Molecules Comprising Shiga Toxin a Subunit Effector Regions and Enriched Compositions Thereof
In force
 · High confidence
In forceHigh confidence
US 11,365,223De-Immunized, Shiga Toxin a Subunit Scaffolds and Cell-Targeting Molecules Comprising the Same
In force
 · Medium confidence
In forceMedium confidence
US 11,389,542Shiga Toxin a Subunit Effector Polypeptides, Shiga Toxin Effector Scaffolds, and Cell-Targeting Molecules for Site-Specific Conjugation
In force
 · Low confidence
In forceLow confidence
10 of 16 patents shown.
Pro members see all 16.
Pro members: see all 16 patents
Also on record, not counted in the 16: 11 patents in force now held by others · 9 lapsed for an unpaid fee · 6 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

4 pending · 20 abandoned · 10 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited